April 2026
The global vaccines market size reached USD 91.97 billion in 2025 and is predicted to hit around USD 170.60 billion by 2035, growing at a notable CAGR of 6.37%.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The global adult vaccines market size was evaluated at USD 19.97 billion in 2025 and is predicted to hit around USD 50.39 billion by 2035, growing at a CAGR of 9.70%.
May 2026
The global pneumococcal vaccines market size was evaluated at 9.04 billion in 2025 and is predicted to hit around USD 16.68 billion by 2035, growing at a CAGR of 6.32%.
April 2026
The global aquaculture vaccines market size is calculated at USD 553.40 million in 2025 and is projected to hit around USD 1,124.65 million by 2035 with a CAGR of 8.27% from 2026 to 2035.
April 2026
The global inactivated vaccines market size is estimated to hit around USD 79.02 billion by 2035 increasing from USD 45.44 billion in 2025, with a CAGR of 5.69%.
February 2026
The global brucellosis vaccines market size is valued at USD 266.78 million in 2025 and is expected to attain around USD 424.75 million by 2035 with a CAGR of 4.76%.
February 2026
The pediatric vaccines market size was valued at USD 66.41 billion in 2025 and is expected to attain around USD 117.32 billion by 2035 with a CAGR of 5.86%.
February 2026
The global canine vaccines market size was evaluated at USD 2.05 billion in 2025 and is predicted to hit around USD 4.23 billion by 2035, growing at a CAGR of 7.51%.
January 2026
The global human papillomavirus Hpv vaccines market size was evaluated at USD 9.73 billion in 2025 and is predicted to hit around USD 29.63 billion by 2035, growing at a CAGR of 11.78%.
December 2025
The global live attenuated vaccines market size is estimated at USD 32.17 billion in 2025 and is expected to hit around USD 82.63 billion by 2034, with a CAGR of 11.05%.
October 2025
The global feline vaccines market size is estimated to hit around USD 3.28 billion by 2034 increasing from USD 1.77 billion in 2025, with a CAGR of 7.12%.
September 2025
The global infectious disease vaccines market size is estimated to hit around USD 72.40 billion by 2034 increasing from USD 36.25 billion in 2024, with a CAGR of 7.17%.
July 2025
The global red biotechnology market size was evaluated at USD 405.84 billion in 2024 and is predicted to hit around USD 680.7 billion by 2034 with a CAGR of 5.3%.